How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Immunology industry affect EB-2 NIW petition outcomes?

The Immunology sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW) RFE Issued

Senior Medical Manager

Immunology · China · 2025-06-16

Processing Time

323 days

Decision Date

2025-06-16

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The petitioner's research on immune pathways and precision medicine for autoimmune diseases was found to have significant merit for public health.

2 Well-positioned to Advance the Endeavor Met

Her M.D. degree, publication record in the top percentiles of clinical medicine, and history of funded research established her as well-positioned.

3 Balance of Interests Met

USCIS determined that the petitioner's unique expertise in translational immunology made it beneficial to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. degree and a record of 9 peer-reviewed journal articles and 1 conference abstract. Her work garnered 131 citations, with papers ranking in the top 10% and 20% of their field, and was supported by two expert recommendation letters and significant funding from national science foundations.

Request for Evidence (RFE)

Successfully Addressed

The RFE challenged the national importance and the petitioner's positioning; the response successfully established the critical nature of her research and her elite standing in the field.

RFE Targets

Substantial Merit and National ImportanceWell-positioned to Advance the Endeavor

Evidence

Evidence Types

Peer Reviewed Publications

Citations

Reference Letters Dependent

Grants

Conference Presentations

Similar Cases

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved

New York 64 days 2025-02-24

The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.

View Case

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved

Tennessee 646 days 2025-11-14

The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.

View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved

Ohio 90 days 2025-01-24

The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.

View Case

Medical Laboratory Technician

Healthcare · Syria

WeGreened EB-2 (NIW) rfe approved

608 days 2025-08-06

The petitioner proposes to continue research in laboratory medicine focusing on the mechanisms of complex medical conditions, including autoimmune and vascular disorders. The work involves investigating specific antibodies and proteins to improve diagnostic accuracy and identify new therapeutic targets. This endeavor aims to reduce misdiagnoses and enable more effective clinical treatments for chronic and rare diseases.

View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-16.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 323 days

RFE Issued

Criteria Met 3 / 3

Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816

Success Rate 53.6%

Sustained 2,046

Dismissed 1,674

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist

Senior Medical Manager

Proposed Endeavor

Framework Evaluation

Why This Petition Was Approved

Request for Evidence (RFE)

Evidence

Similar Cases

Research Scientist

Postdoctoral Researcher

Postdoctoral Researcher

Medical Laboratory Technician

Frequently Asked Questions

Browse More Cases

At a Glance

EB-2 (NIW) Case Data

Related Pages

Get Case Insights